The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.

scientific article published on September 2006

The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4088/JCP.V67N0910
P698PubMed publication ID17017826

P2093author name stringWen Xu
Glenn A Phillips
Dieter Naber
Suraja M Roychowdhury
David L Van Brunt
P433issue9
P921main subjectquality of lifeQ13100823
P304page(s)1397-1403
P577publication date2006-09-01
P1433published inThe Journal of Clinical PsychiatryQ7743563
P1476titleThe relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone
P478volume67

Reverse relations

cites work (P2860)
Q38051283An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine
Q41510821Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
Q40664835Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS).
Q37214661Do effectiveness ("real world") studies on antipsychotics tell us the real truth?
Q37917728Effectiveness studies: advantages and disadvantages.
Q35232135How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review
Q36920148Measuring health-related quality of life in drug clinical trials: is it given due importance?
Q94235795Olanzapine dose for people with schizophrenia
Q24236545Olanzapine versus other atypical antipsychotics for schizophrenia
Q47374764Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia.
Q33291585Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings
Q38113746The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia
Q24240260Ziprasidone versus other atypical antipsychotics for schizophrenia

Search more.